Browsing Category

Sponsored Content

13 posts

Engineering Excellence In High Potency Manufacturing: Indena’s Integrated CDMO Platform for HPAPIs and ADCs 

The HPAPI momentum: growth, complexity and the outsourcing imperative Highly potent active pharmaceutical ingredients (HPAPIs) are no longer a niche. They are at the center of modern pharmaceutical innovation. As oncology, targeted therapies,…

The CDMO Reset: Why Biotech Needs Partners, Not Just Vendors 

One thing has always been true about the CDMO landscape—it is constantly changing and rapidly evolving. Today, the stakes are higher, and the complexity is greater than ever before. This…

Sustainability in inhalation: From global agreement to industry action 

In 2016, the United Nations took a decisive step to protect the future of both the planet and public health. Building on the success of the 1987 Montreal Protocol, the…

Flexible Fill–Finish for an Unpredictable Market  

If the last five years have taught us anything, it is that fill–finish capacity can disappear faster than anyone expects.  The industry moved from pandemic-driven demand to another surge almost immediately.…

How Reagent Purity Impacts API Manufacturing for Oligonucleotides and Peptides 

This article was originally published by Aurorium  The therapeutic potential of oligonucleotides and peptides is reshaping the landscape of modern medicine. These complex molecules, often referred to collectively as TIDES…

NaOH Solution: Benefits of Vertical Integration in the Pharma Supply Chain

This article was originally published by Aurorium In today’s fast-moving world, businesses need reliable supply chains to keep things running smoothly. This is especially true for essential materials like Sodium…

Latest Investments in High Containment Confirm Indena’s Excellence in CDMO Services 

Since the 1990s, Indena has acted as a strategic partner in CDMO services, going beyond the mere client–supplier relationship, with full commitment to developing new high-potency active pharmaceutical ingredients (HPAPIs)…

Overcoming Barriers To Patient Adherence With A Novel Dosage Form 

To make administration of an effective drug treatment easier for patients with hand tremors or swallowing difficulties, Adare Pharma Solutions developed a convenient sprinkle formulation.  THE CHALLENGE Patients who experience tremors…

OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP 

GTP Bioways Group is a French company operating as a biotech CDMO (contract development and manufacturing organization), specializing in R&D services, process development, and production of monoclonal antibodies (mAbs), enzymes,…

Global Scenario: Opportunities and Challenges in Peptides 

Sponsored by Olon  In just the last five years, the US Food and Drug Administration (FDA) has approved no fewer than 14 peptides with therapeutic activities. Today, there are around…